Form 4: Ceribell CEO Sells Shares, Exercises Options Under 10b5-1 Plan

Ceribell Inc.'s President and CEO, Xingjuan Chao, reported sales of common stock and exercise of stock options under a Rule 10b5-1 trading plan.

Summary

• Xingjuan Chao, President and CEO of Ceribell, Inc., reported multiple transactions involving the company's common stock.
• All reported transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
• On November 20, 2025, 2,887 shares were disposed of at $13.64 to cover tax liabilities.
• On January 5, 2026, a total of 79,000 shares of common stock were sold at weighted average prices ranging from $21.17 to $21.31.
• Concurrently on January 5, 2026, 25,000 shares were acquired through the exercise of stock options at an exercise price of $4.7 per share.
• Following these transactions, the reporting person directly beneficially owns 741,248 shares of common stock.
• An additional 369,088 shares are indirectly beneficially owned through the ACP 2021 Trust, where the reporting person is a co-trustee.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While there are significant sales, they are offset by option exercises and conducted under a 10b5-1 plan, which suggests pre-planned activity rather than a negative signal about the company's immediate prospects. The net effect on direct beneficial ownership is a decrease, but the overall context of compensation and planned transactions keeps the sentiment neutral.

Positives

• The exercise of stock options at a significantly lower price ($4.7) compared to the market sale prices (ranging from $21.17 to $21.31) indicates a profitable transaction for the insider.
• Transactions were conducted under a Rule 10b5-1 trading plan, suggesting pre-planned activity rather than a reaction to immediate company news or performance.

Negatives

• The President and CEO sold a total of 79,000 shares of common stock, which represents a reduction in direct equity exposure, although this was part of a pre-arranged plan.

Future Outlook

NA

Industry Context

This Form 4 filing details routine insider transactions for Ceribell Inc.'s CEO. Such filings are common across all industries for publicly traded companies and do not inherently reflect specific industry trends, but rather individual executive compensation and portfolio management strategies, often pre-planned under Rule 10b5-1.

Related Party Transactions

• The reporting person is a co-trustee of the ACP 2021 Trust, which indirectly holds 369,088 shares of common stock. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.

Stakeholder Impact

• Shareholders: The sale of shares by the CEO could be perceived negatively by some, but the execution under a 10b5-1 plan mitigates concerns about immediate insider sentiment. The exercise of options at a low price demonstrates the value of executive compensation plans.
• Employees: The continued employment condition for option vesting reinforces the link between executive tenure and equity benefits.

Key Dates

Recommendation

The Form 4 filing details pre-planned insider transactions (sales and option exercises) by the CEO under a Rule 10b5-1 plan. While there are significant sales, these are routine for executive compensation and portfolio management and do not signal a change in the company's fundamental outlook. Without additional information on company performance or strategic shifts, these transactions alone do not warrant a change in investment recommendation. Investors should 'hold' and await further financial disclosures for a more comprehensive assessment.

Keywords

Ceribell Inc., CBLL, Form 4, Insider Trading, Stock Options, Share Sale, CEO, Xingjuan Chao, Rule 10b5-1